Study of hypertensive subjects with diabetes as co-morbidity


  • Santosh B. Salagre Department of Medicine, Seth G S Medical College, Mumbai, Maharashtra, India
  • Shobha M. Itolikar Department of Medicine, Seth G S Medical College, Mumbai, Maharashtra, India
  • Suyog N. Bhagwat Department of Medicine, Seth G S Medical College, Mumbai, Maharashtra, India



Co-morbidities, Diabetes, Hypertension


Background: Combined presence of diabetes and hypertension increases the chances of various complications manifold than individually. Together, they accelerate the development of left ventricular hypertrophy, coronary artery disease, renal dysfunction, diabetic retinopathy and cerebrovascular diseases.

Methods: After ethical considerations this observational study was carried out to identify the clinical, laboratory and end-organ profile of Hypertensive subjects who also had Diabetes; this cohort was also compared with subjects who had hypertension only.

Results: The prevalence of hypertensive subjects with diabetes as co-morbidity was 10.26%. 26.4% subjects had family history of diabetes and 20.4% had family history of hypertension. The mean diastolic blood pressure (83.66±12.0) was significantly higher in hypertensive diabetes group, than the subjects with hypertension only (76.98±6.46) and the difference was statistically significant (p <0.0001). 51.9% of hypertensive females with diabetes had significantly higher (p 0.0003) central obesity. Macrovascular damage was slightly more common in females and microvascular damage was common in male hypertensive diabetic subjects. Out of 102 patients having end organ damage 37.25% had single organ involvement and 62.75% had multiple organ involvement. Retinopathy (33.2%) was commonest followed by renal (27.6%), cardiovascular (16.2%) and cerebrovascular (14.8%). Hypertensive diabetic patients had higher occurrence of end organ damage reflecting the impact of diabetes-hypertension co-morbidity on target organs.

Conclusions: Given the increasing rates of coronary artery disease among Indians, especially at a younger age, 5understanding and successfully managing this deadly duo may hold the key to reducing cardiovascular mortality in India.


World Health Organization: Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. December 2010. healthinfo/ global_burden_ disease/ GlobalHealthRisks_report_full.pdf

Williams G. Hypertension in diabetes. In: Pickup J, Williams G, eds. Textbook of Diabetes. London: Blackwell Scientific Publications. 1991:719-32.

Parving HH, Andersen AR, Smidt UM, Oxenboll B, Edsberg B, Christiansen JS. Diabetic nephropathy and arterial hypertension. Diabetologia. 1983;24:10-2.

Sahay BK. API-ICP guidelines on diabetes 2007. J Assoc Physicians India. 2007;55:1-50.

Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: the Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol. 2001;38:682-7.

Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study. Diabetologia. 2011.

Joshi SR, Saboo B, Vadivale M, Dani SI, Mithal A, Kaul U, et al. Prevalence of diagnosed and undiagnosed diabetes and hypertension in India- Results from the Screening India’s Dual Epidemic-SITE study. Diabetes Technol Ther. 2012;14(1):8-15.

Thakur S, Raina S, Thakur S, Negi PC, Verma BS. Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh. Indian J Endocrinol Metab. 2013;17:723-6.

Chin-Neng Hsu. Prevalence and characteristics of the metabolic syndrome in Chinese Hypertensive patients: A Hospital based observation; Acta Cardiol Sin. 2005;21:89-97.

Yesein N, Ahmad M, Matrook F, Nasir L, Froelicher ES. Metabolic syndrome in patients with hypertension attending a family practice clinic in Jordan, Eastern Mediterranean Health J. 2010;16(4):375-80.

Eguchi K, Kario K, Shimada K. Greater impact of coexistence of Hypertension and diabetes on silent cerebral infarcts. Stroke. 2003;34:2471-4.

Olinto MT, Nacul LC, Gigante DP, Costa JS, Menezes AM, Macedo S. Waist circumference as a determinant of hypertension and diabetes in Brazilian women: a population-based study. Public Health Nutr. 2004;7(5):629-35.




How to Cite

Salagre, S. B., Itolikar, S. M., & Bhagwat, S. N. (2017). Study of hypertensive subjects with diabetes as co-morbidity. International Journal of Research in Medical Sciences, 5(2), 456–462.



Original Research Articles